News

New cancer models could help personalize lymphoma treatments

Published:18.12.24 — Scientists at EPFL have developed "lymphomoids," a pioneering cancer model that preserves the structure and multicellular composition of lymphoma tumors in the lab. Lymphomoids offer an innovative way to test the efficacy of lymphoma treatments and better predict individual responses.

AI-Powered Virtual Cell Could Become Biology's Universal Simulator

Published:12.12.24 — More than 40 researchers from across the fields of AI and biology, including from EPFL, have set out their vision for AI-powered Virtual Cells, arguing that these have the potential to revolutionize the scientific process.

Friedhelm Hummel awarded Fürst Donnersmarck Prize

Published:11.12.24 — Friedhelm Hummel, head of EPFL's Hummel Lab and a core member of the NeuroX Institute, has been recognized for his groundbreaking research in neurorehabilitation with the Fürst Donnersmarck Prize.

Two appointments at the School of Life Sciences

Published:05.12.24 — The Board of the Swiss Federal Institutes of Technology has announced the appointment of professors at EPFL. Among them, are Professors Markus Jeschek and Raphael Gottardo at the School of Life Sciences.

Stimulating hypothalamus restores walking in paralyzed patients

Published:02.12.24 — The discovery that an unexpected brain region is crucial for walking recovery in mice with spinal cord injuries has led a deep brain stimulation therapy in humans. The approach restored enough leg control in two individuals with partial spinal injuries to walk unaided and even climb stairs.